QGel has developed a solution that enables scientists to mimic the complex physiology of the human body for better predicting the efficacy of treatments for patients. The company has been developing assay kits for drug discovery since 2013. Soon, QGel technology could be used for personalized medicine to identify the right treatment for individual cancer patients.
Source: Startupticker